TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7926602
log Bayes Factor = 7.09098
Chromosome 11   position 107,054,642  (GRCh37) Explore rs7926602 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
I25 Chronic ischaemic heart disease
0.000 0.000 1.000
I10 Essential (primary) hypertension
0.000 0.000 1.000
I20-I25 Ischaemic heart diseases
0.000 0.002 0.998
I25.9 Chronic ischaemic heart disease, unspecified
0.000 0.002 0.998
I20 Angina pectoris
0.000 0.004 0.996
I25.2 Old myocardial infarction
0.000 0.008 0.992
I20.8 Other forms of angina pectoris
0.000 0.020 0.980
I25.8 Other forms of chronic ischaemic heart disease
0.000 0.026 0.974
I20.9 Angina pectoris, unspecified
0.000 0.035 0.965
I21 Acute myocardial infarction
0.000 0.043 0.957
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.057 0.943
I25.4 Coronary artery aneurysm
0.000 0.132 0.868
I21.3 Acute transmural myocardial infarction of unspecified site
0.000 0.186 0.814
I20.1 Angina pectoris with documented spasm
0.000 0.223 0.777
I25.1 Atherosclerotic heart disease
0.000 0.230 0.770
I25.0 Atherosclerotic cardiovascular disease, so described
0.000 0.242 0.758
I21.4 Acute subendocardial myocardial infarction
0.000 0.255 0.745
I23 Certain current complications following acute myocardial infarction
0.000 0.275 0.725
I25.6 Silent myocardial ischaemia
0.000 0.283 0.717
I21.2 Acute transmural myocardial infarction of other sites
0.000 0.306 0.694
I21.X Presumed acute myicardial infaction (unconfirmed)
0.000 0.314 0.686
I22 Subsequent myocardial infarction
0.000 0.329 0.671
I10-I15 Hypertensive diseases
0.000 0.337 0.663
I15 Secondary hypertension
0.000 0.392 0.608
I20.0 Unstable angina
0.000 0.394 0.606
I24 Other acute ischaemic heart diseases
0.000 0.397 0.603
I25.5 Ischaemic cardiomyopathy
0.000 0.397 0.603
I22.8 Subsequent myocardial infarction of other sites
0.000 0.431 0.569
I22.1 Subsequent myocardial infarction of inferior wall
0.000 0.444 0.556
I15.1 Hypertension secondary to other renal disorders
0.000 0.458 0.542
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.000 0.466 0.534
I23.8 Other current complications following acute myocardial infarction
0.000 0.470 0.530
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.000 0.480 0.520
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.000 0.480 0.520
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.000 0.480 0.520
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.000 0.480 0.520
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.000 0.480 0.520
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.000 0.480 0.520
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.000 0.480 0.520
I15.9 Seconday hypertension, unspecified
0.000 0.488 0.512
I24.1 Dressler's syndrome
0.000 0.494 0.506
Chapter IX Diseases of the circulatory system
0.000 0.518 0.482
I13 Hypertensive heart and renal disease
0.000 0.560 0.440
I15.8 Other secondary hypertension
0.000 0.564 0.436
I15.0 Renovascular hypertension
0.000 0.564 0.436
I15.2 Hypertension secondary to endocrine disorders
0.000 0.577 0.423
I11 Hypertensive heart disease
0.000 0.620 0.379
I21.9 Acute myocardial infarction, unspecified
0.000 0.622 0.378
I25.3 Aneurysm of heart
0.001 0.656 0.343
I00-I02 Acute rheumatic fever
0.000 0.658 0.342
I22.0 Subsequent myocardial infarction of anterior wall
0.000 0.664 0.336
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.684 0.315
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.684 0.315
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.684 0.315
I95-I99 Other and unspecified disorders of the circulatory system
0.000 0.690 0.310
I21.0 Acute transmural myocardial infarction of anterior wall
0.000 0.719 0.281
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.719 0.280
I97 Postprocedural disorders of circulatory system, not elsewhere classified
0.000 0.725 0.275
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.733 0.267
I11.0 Hypertensive heart disease with (congestive) heart failure
0.000 0.745 0.255
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified
0.000 0.752 0.248
I02 Rheumatic chorea
0.000 0.754 0.245
I01 Rheumatic fever with heart involvement
0.000 0.754 0.245
I00 Rheumatic fever without mention of heart involvement
0.000 0.758 0.242
I97.1 Other functional disturbances following cardiac surgery
0.000 0.779 0.221
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.796 0.204
I95 Hypotension
0.000 0.796 0.204
I24.9 Acute ischaemic heart disease, unspecified
0.000 0.797 0.203
I97.9 Postprocedural disorder of circulatory system, unspecified
0.000 0.802 0.197
I97.0 Postcardiotomy syndrome
0.000 0.802 0.197
I99 Other and unspecified disorders of circulatory system
0.000 0.808 0.192
I12 Hypertensive renal disease
0.000 0.811 0.189
I95.1 Orthostatic hypotension
0.000 0.816 0.184
I01.9 Acute rheumatic heart disease, unspecified
0.000 0.824 0.176
I01.8 Other acute rheumatic heart disease
0.000 0.824 0.176
I01.2 Acute rheumatic myocarditis
0.000 0.824 0.176
I01.1 Acute rheumatic endocarditis
0.000 0.824 0.176
I01.0 Acute rheumatic pericarditis
0.000 0.824 0.176
I02.9 Rheumatic chorea without heart involvement
0.000 0.824 0.176
I02.0 Rheumatic chorea with heart involvement
0.000 0.824 0.176
I97.2 Postmastectomy lymphoedema syndrome
0.000 0.826 0.174
I95.0 Idiopathic hypotension
0.000 0.828 0.172
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation
0.000 0.864 0.136
I95.2 Hypotension due to drugs
0.000 0.877 0.123
I98 Other disorders of circulatory system in diseases classified elsewhere
0.000 0.879 0.121
I95.8 Other hypotension
0.000 0.897 0.103
I28 Other diseases of pulmonary vessels
0.000 0.900 0.100
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere
0.000 0.913 0.087
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere
0.000 0.913 0.087
I98.0 Cardiovascular syphilis
0.000 0.913 0.087
I12.9 Hypertensive renal disease without renal failure
0.000 0.916 0.084
I05-I09 Chronic rheumatic heart diseases
0.000 0.917 0.083
I24.8 Other forms of acute ischaemic heart disease
0.000 0.920 0.080
I28.8 Other specified diseases of pulmonary vessels
0.000 0.926 0.074
I28.9 Disease of pulmonary vessels, unspecified
0.000 0.928 0.071
I28.1 Aneurysm of pulmonary artery
0.000 0.928 0.071
I28.0 Arteriovenous fistula of pulmonary vessels
0.000 0.928 0.071
I09 Other rheumatic heart diseases
0.000 0.943 0.057
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere
0.001 0.945 0.055
I06 Rheumatic aortic valve diseases
0.000 0.947 0.053
I98.2 Oesophageal varices in diseases classified elsewhere
0.000 0.950 0.050
T39.1 4-Aminophenol derivatives
0.000 0.951 0.049
I07 Rheumatic tricuspid valve diseases
0.000 0.951 0.049
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.951 0.049
I95.9 Hypotension, unspecified
0.000 0.952 0.048
T39.0 Salicylates
0.000 0.952 0.048
I26 Pulmonary embolism
0.000 0.955 0.045
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.955 0.045
I09.8 Other specified rheumatic heart diseases
0.000 0.959 0.041
I09.2 Chronic rheumatic pericarditis
0.000 0.959 0.041
I09.1 Rheumatic diseases of endocardium, valve unspecified
0.000 0.959 0.041
I09.0 Rheumatic myocarditis
0.000 0.959 0.041
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge
0.000 0.960 0.040
I06.1 Rheumatic aortic insufficiency
0.000 0.960 0.039
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.961 0.039
I09.9 Rheumatic heart disease, unspecified
0.000 0.962 0.038
I06.8 Other rheumatic aortic valve diseases
0.000 0.962 0.038
I06.2 Rheumatic aortic stenosis with insufficiency
0.000 0.962 0.038
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.963 0.037
C54.1 Endometrium
0.036 0.964 0.000
I06.9 Rheumatic aortic valve disease, unspecified
0.000 0.964 0.035
I07.9 Tricuspid valve disease, unspecified
0.000 0.965 0.035
I07.8 Other tricuspid valve diseases
0.000 0.965 0.035
I07.2 Tricuspid stenosis with insufficiency
0.000 0.965 0.035
I07.0 Tricuspid stenosis
0.000 0.965 0.035
T39.4 Antirheumatics, not elsewhere classified
0.000 0.965 0.035
T39.2 Pyrazolone derivatives
0.000 0.965 0.035
I06.0 Rheumatic aortic stenosis
0.000 0.966 0.034
I70-I79 Diseases of arteries, arterioles and capillaries
0.000 0.971 0.029
I05 Rheumatic mitral valve diseases
0.000 0.973 0.026
I70 Atherosclerosis
0.000 0.974 0.026
I26.0 Pulmonary embolism with mention of acute cor pulmonale
0.000 0.975 0.025
I08 Multiple valve diseases
0.000 0.975 0.025
I07.1 Tricuspid insufficiency
0.000 0.975 0.025
I27 Other pulmonary heart diseases
0.000 0.975 0.024
I70.2 Atherosclerosis of arteries of the extremities
0.000 0.977 0.023
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.000 0.977 0.023
I70.0 Atherosclerosis of aorta
0.000 0.978 0.022
I77 Other disorders of arteries and arterioles
0.000 0.978 0.022
I05.1 Rheumatic mitral insufficiency
0.000 0.978 0.022
I08.1 Disorders of both mitral and tricuspid valves
0.000 0.979 0.021
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.000 0.979 0.021
I70.8 Atherosclerosis of other arteries
0.000 0.980 0.020
I70.00 Atherosclerosis of aorta (without gangrene)
0.000 0.980 0.020
I77.8 Other specified disorders of arteries and arterioles
0.000 0.981 0.019
I70.9 Generalised and unspecified atherosclerosis
0.000 0.981 0.019
K06 Other disorders of gingiva and edentulous alveolar ridge
0.000 0.981 0.019
I05.8 Other mitral valve diseases
0.000 0.981 0.018
I08.9 Multiple valve disease, unspecified
0.000 0.981 0.019
I08.8 Other multiple valve diseases
0.000 0.981 0.019
I77.6 Arteritis, unspecified
0.000 0.982 0.018
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.000 0.982 0.018
I27.1 Kyphoscoliotic heart disease
0.000 0.982 0.018
I72 Other aneurysm
0.000 0.982 0.018
I70.21 Atherosclerosis of arteries of extremities (with gangrene)
0.000 0.983 0.017
I27.8 Other specified pulmonary heart diseases
0.000 0.983 0.017
J44 Other chronic obstructive pulmonary disease
0.000 0.983 0.017
I05.2 Mitral stenosis with insufficiency
0.000 0.983 0.016
I77.2 Rupture of artery
0.000 0.983 0.016
I70.1 Atherosclerosis of renal artery
0.000 0.984 0.016
I70.01 Atherosclerosis of aorta (with gangrene)
0.000 0.984 0.016
I77.0 Arteriovenous fistula, acquired
0.000 0.984 0.016
I77.3 Arterial fibromuscular dysplasia
0.000 0.984 0.016
C54 Malignant neoplasm of corpus uteri
0.016 0.984 0.000
I77.5 Necrosis of artery
0.000 0.984 0.016
I77.4 Coeliac artery compression syndrome
0.000 0.984 0.016
I27.9 Pulmonary heart disease, unspecified
0.000 0.984 0.016
I72.4 Aneurysm of artery of lower extremity
0.000 0.984 0.016
I72.3 Aneurysm of iliac artery
0.000 0.984 0.016
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.000 0.984 0.015
I12.0 Hypertensive renal disease with renal failure
0.000 0.984 0.015
I70.80 Atherosclerosis of other arteries (without gangrene)
0.000 0.985 0.015
K06.0 Gingival recession
0.000 0.985 0.015
K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified
0.000 0.985 0.015
I77.1 Stricture of artery
0.000 0.985 0.015
I70.81 Atherosclerosis of other arteries (with gangrene)
0.000 0.985 0.014
Z29.2 Other prophylactic chemotherapy
0.000 0.985 0.015
Z29 Need for other prophylactic measures
0.000 0.986 0.014
Z29.0 Isolation
0.000 0.986 0.014
I70.91 Generalized and unspecified atherosclerosis (with gangrene)
0.000 0.986 0.014
I70.90 Generalized and unspecified atherosclerosis (without gangrene)
0.000 0.986 0.014
Z29.1 Prophylactic immunotherapy
0.000 0.986 0.014
I69.3 Sequelae of cerebral infarction
0.000 0.986 0.014
K06.1 Gingival enlargement
0.000 0.986 0.013
C34.9 Bronchus or lung, unspecified
0.000 0.987 0.013
K06.2 Gingival and edentulous alveolar ridge lesions associated with trauma
0.000 0.987 0.013
I72.6 Aneurysm and dissection of vertebral artery
0.000 0.987 0.013
I72.5 Aneurysm and dissection of other precerebral arteries
0.000 0.987 0.013
I72.2 Aneurysm of renal artery
0.000 0.987 0.012
I73 Other peripheral vascular diseases
0.000 0.988 0.012
I60-I69 Cerebrovascular diseases
0.000 0.988 0.012
I70.11 Atherosclerosis of renal artery (with gangrene)
0.000 0.988 0.012
I69 Sequelae of cerebrovascular disease
0.000 0.988 0.012
C54.9 Corpus uteri, unspecified
0.012 0.988 0.000
I72.1 Aneurysm of artery of upper extremity
0.000 0.988 0.012
C54.8 Overlapping lesion of corpus uteri
0.012 0.988 0.000
C54.3 Fundus uteri
0.012 0.988 0.000
C54.2 Myometrium
0.012 0.988 0.000
C54.0 Isthmus uteri
0.012 0.988 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.000 0.988 0.012
I05.0 Mitral stenosis
0.001 0.988 0.011
I79.1 Aortitis in diseases classified elsewhere
0.000 0.989 0.011
I79.0 Aneurysm of aorta in diseases classified elsewhere
0.000 0.989 0.011
C77.1 Intrathoracic lymph nodes
0.000 0.989 0.011
I08.0 Disorders of both mitral and aortic valves
0.000 0.989 0.011
Z29.9 Prophylactic measure, unspecified
0.000 0.989 0.010
Z29.8 Other specified prophylactic measures
0.000 0.989 0.010
I72.0 Aneurysm of carotid artery
0.000 0.990 0.010
I73.1 Thromboangiitis obliterans [Buerger]
0.000 0.990 0.010
J44.8 Other specified chronic obstructive pulmonary disease
0.000 0.990 0.010
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
0.000 0.990 0.010
E21.3 Hyperparathyroidism, unspecified
0.000 0.990 0.010
I70.10 Atherosclerosis of renal artery (without gangrene)
0.000 0.990 0.009
I68 Cerebrovascular disorders in diseases classified elsewhere
0.000 0.991 0.009
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.991 0.009
I69.8 Sequelae of other and unspecified cerebrovascular diseases
0.000 0.991 0.009
I79.2 Peripheral angiopathy in diseases classified elsewhere
0.000 0.991 0.009
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.000 0.991 0.009
I72.9 Aneurysm of unspecified site
0.000 0.991 0.009
K56.4 Other impaction of intestine
0.000 0.991 0.009
I73.8 Other specified peripheral vascular diseases
0.000 0.991 0.009
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.992 0.008
I66.9 Occlusion and stenosis of unspecified cerebral artery
0.000 0.992 0.008
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.992 0.008
I72.8 Aneurysm of other specified arteries
0.000 0.992 0.008
I08.2 Disorders of both aortic and tricuspid valves
0.001 0.992 0.007
I73.9 Peripheral vascular disease, unspecified
0.000 0.992 0.008
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.992 0.008
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.992 0.008
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.992 0.008
I69.2 Sequelae of other nontraumatic intracranial haemorrhage
0.000 0.992 0.007
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.992 0.007
T50.4 Drugs affecting uric acid metabolism
0.000 0.993 0.007
J44.9 Chronic obstructive pulmonary disease, unspecified
0.000 0.993 0.007
I68.0 Cerebral amyloid angiopathy
0.000 0.993 0.007
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries
0.000 0.993 0.007
I66.8 Occlusion and stenosis of other cerebral artery
0.000 0.993 0.007
I66.2 Occlusion and stenosis of posterior cerebral artery
0.000 0.993 0.007
I66.1 Occlusion and stenosis of anterior cerebral artery
0.000 0.993 0.007
T50.8 Diagnostic agents
0.000 0.993 0.007
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.993 0.007
I78 Diseases of capillaries
0.000 0.993 0.007
I68.8 Other cerebrovascular disorders in diseases classified elsewhere
0.000 0.993 0.007
I68.2 Cerebral arteritis in other diseases classified elsewhere
0.000 0.993 0.007
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere
0.000 0.993 0.007
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.993 0.007
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.993 0.007
I08.3 Combined disorders of mitral, aortic and tricuspid valves
0.000 0.993 0.007
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.993 0.007
I27.0 Primary pulmonary hypertension
0.000 0.993 0.007
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
0.000 0.993 0.007
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.993 0.007
I66.0 Occlusion and stenosis of middle cerebral artery
0.000 0.993 0.007
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.993 0.007
W18.3 Sports and athletics area
0.007 0.993 0.000
I66.3 Occlusion and stenosis of cerebellar arteries
0.000 0.993 0.006
I05.9 Mitral valve disease, unspecified
0.001 0.993 0.006
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.994 0.006
T46.1 Calcium-channel blockers
0.000 0.994 0.006
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.994 0.006
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.994 0.006
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.994 0.006
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.994 0.006
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.994 0.006
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.994 0.006
T44.0 Anticholinesterase agents
0.000 0.994 0.006
I61 Intracerebral haemorrhage
0.000 0.994 0.006
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.994 0.006
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.994 0.006
T50.7 Analeptics and opioid receptor antagonists
0.000 0.994 0.006
T50.5 Appetite depressants
0.000 0.994 0.006
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.994 0.006
T50.1 Loop [high-ceiling] diuretics
0.000 0.994 0.006
T50.0 Mineralocorticoids and their antagonists
0.000 0.994 0.006
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.994 0.006
T48.5 Anti-common-cold drugs
0.000 0.994 0.006
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.994 0.006
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.994 0.006
T46.7 Peripheral vasodilators
0.000 0.994 0.006
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.994 0.006
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.994 0.006
T48.4 Expectorants
0.000 0.994 0.006
T48.3 Antitussives
0.000 0.994 0.006
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.994 0.006
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.994 0.006
T48.0 Oxytocic drugs
0.000 0.994 0.006
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.994 0.006
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.994 0.006
Z20-Z29 Persons with potential health hazards related to communicable diseases
0.000 0.994 0.006
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.994 0.006
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.994 0.006
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.994 0.006
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
0.006 0.994 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.994 0.005
T37.5 Antiviral drugs
0.000 0.994 0.005
T37.4 Anthelminthics
0.000 0.994 0.005
T37.3 Other antiprotozoal drugs
0.000 0.994 0.005
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.994 0.005
T37.1 Antimycobacterial drugs
0.000 0.994 0.005
T37.0 Sulphonamides
0.000 0.994 0.005
I77.9 Disorder of arteries and arterioles, unspecified
0.000 0.994 0.005
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status
0.000 0.994 0.006
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.995 0.005
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.995 0.005
I65.8 Occlusion and stenosis of other precerebral artery
0.000 0.995 0.005
I78.9 Disease of capillaries, unspecified
0.000 0.995 0.005
I42.6 Alcoholic cardiomyopathy
0.000 0.995 0.005
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.995 0.005
T36 Poisoning by systemic antibiotics
0.000 0.995 0.005
T41.5 Therapeutic gases
0.000 0.995 0.005
T41.4 Anaesthetic, unspecified
0.000 0.995 0.005
T41.3 Local anaesthetics
0.000 0.995 0.005
T41.2 Other and unspecified general anaesthetics
0.000 0.995 0.005
T41.1 Intravenous anaesthetics
0.000 0.995 0.005
T41.0 Inhaled anaesthetics
0.000 0.995 0.005
T45.5 Anticoagulants
0.000 0.995 0.005
T49.9 Topical agent, unspecified
0.000 0.995 0.005
T49.8 Other topical agents
0.000 0.995 0.005
T49.7 Dental drugs, topically applied
0.000 0.995 0.005
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.995 0.005
T49.5 Ophthalmological drugs and preparations
0.000 0.995 0.005
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.995 0.005
T49.3 Emollients, demulcents and protectants
0.000 0.995 0.005
T49.2 Local astringents and local detergents
0.000 0.995 0.005
T49.1 Antipruritics
0.000 0.995 0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.995 0.005
I61.8 Other intracerebral haemorrhage
0.000 0.995 0.005
T43.6 Psychostimulants with abuse potential
0.000 0.995 0.005
I65.1 Occlusion and stenosis of basilar artery
0.000 0.995 0.005
I65.0 Occlusion and stenosis of vertebral artery
0.000 0.995 0.005
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.995 0.005
I69.0 Sequelae of subarachnoid haemorrhage
0.000 0.995 0.005
I65.9 Occlusion and stenosis of unspecified precerebral artery
0.000 0.995 0.005
Z37.2 Twins, both liveborn
0.005 0.995 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.995 0.005
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.995 0.005
I61.6 Intracerebral haemorrhage, multiple localised
0.000 0.995 0.005
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.995 0.005
I83.1 Varicose veins of lower extremities with inflammation
0.000 0.995 0.005
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.995 0.005
I61.9 Intracerebral haemorrhage, unspecified
0.000 0.995 0.005
T43.2 Other and unspecified antidepressants
0.000 0.995 0.005
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.995 0.005
T43.9 Psychotropic drug, unspecified
0.000 0.995 0.005
M79.00 Rheumatism, unspecified (Multiple sites)
0.000 0.995 0.005
I62 Other nontraumatic intracranial haemorrhage
0.000 0.995 0.005
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.995 0.005
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.995 0.005
I78.8 Other diseases of capillaries
0.000 0.995 0.005
T47.2 Stimulant laxatives
0.000 0.995 0.005
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.995 0.005
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.995 0.005
T47.7 Emetics
0.000 0.995 0.005
T47.6 Antidiarrhoeal drugs
0.000 0.995 0.005
T47.5 Digestants
0.000 0.995 0.005
T47.4 Other laxatives
0.000 0.995 0.005
T47.3 Saline and osmotic laxatives
0.000 0.995 0.005
T47.0 Histamine H(2)-receptor antagonists
0.000 0.995 0.005
I26.9 Pulmonary embolism without mention of acute cor pulmonale
0.000 0.995 0.005
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.995 0.004
T45.8 Other primarily systemic and haematological agents
0.000 0.995 0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.995 0.004
T45.6 Fibrinolysis-affecting drugs
0.000 0.995 0.004
T45.4 Iron and its compounds
0.000 0.995 0.004
T45.3 Enzymes, not elsewhere classified
0.000 0.995 0.004
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.000 0.995 0.005
T45.2 Vitamins, not elsewhere classified
0.000 0.995 0.004
I61.4 Intracerebral haemorrhage in cerebellum
0.000 0.995 0.004
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)
0.005 0.995 0.000
K04.8 Radicular cyst
0.000 0.996 0.004
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.996 0.004
I71 Aortic aneurysm and dissection
0.000 0.996 0.004
Z28 Immunisation not carried out
0.000 0.996 0.004
Z27 Need for immunisation against combinations of infectious diseases
0.000 0.996 0.004
Z25 Need for immunisation against other single viral diseases
0.000 0.996 0.004
Z23 Need for immunisation against single bacterial diseases
0.000 0.996 0.004
I42.1 Obstructive hypertrophic cardiomyopathy
0.000 0.996 0.004
I42.0 Dilated cardiomyopathy
0.000 0.996 0.004
Z24 Need for immunisation against certain single viral diseases
0.000 0.996 0.004
I42 Cardiomyopathy
0.000 0.996 0.004
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.996 0.004
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries
0.000 0.996 0.004
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
0.000 0.996 0.004
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium
0.004 0.996 0.000
N48.8 Other specified disorders of penis
0.000 0.996 0.004
N18.3 Chronic kidney disease, stage 3
0.000 0.996 0.004
E21.2 Other hyperparathyroidism
0.000 0.996 0.004
T36.9 Systemic antibiotic, unspecified
0.000 0.996 0.004
T36.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
T36.6 Rifamycins
0.000 0.996 0.004
T36.5 Aminoglycosides
0.000 0.996 0.004
T36.3 Macrolides
0.000 0.996 0.004
T36.2 Chloramphenicol group
0.000 0.996 0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.996 0.004
I61.2 Intracerebral haemorrhage in hemisphere, unspecified
0.000 0.996 0.004
E21.4 Other specified disorders of parathyroid gland
0.000 0.996 0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.996 0.004
Z20 Contact with and exposure to communicable diseases
0.000 0.996 0.004
T36.4 Tetracyclines
0.000 0.996 0.004
Z26 Need for immunisation against other single infectious diseases
0.000 0.996 0.004
T38.9 Other and unspecified hormone antagonists
0.000 0.996 0.004
T38.7 Androgens and anabolic congeners
0.000 0.996 0.004
T38.5 Other oestrogens and progestogens
0.000 0.996 0.004
T38.4 Oral contraceptives
0.000 0.996 0.004
T38.2 Antithyroid drugs
0.000 0.996 0.004
T38.0 Glucocorticoids and synthetic analogues
0.000 0.996 0.004
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.996 0.004
I61.3 Intracerebral haemorrhage in brain stem
0.000 0.996 0.004
N48.0 Leukoplakia of penis
0.000 0.996 0.004
Z83.5 Family history of eye and ear disorders
0.000 0.996 0.004
M79.09 Rheumatism, unspecified (Site unspecified)
0.000 0.996 0.004
T36.8 Other systemic antibiotics
0.000 0.996 0.004
T42.0 Hydantoin derivatives
0.000 0.996 0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.996 0.004
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
0.004 0.996 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.996 0.003
I42.7 Cardiomyopathy due to drugs and other external agents
0.000 0.996 0.004
A49.1 Streptococcal infection, unspecified
0.004 0.996 0.000
E24.0 Pituitary-dependent Cushing's disease
0.000 0.996 0.004
I65.2 Occlusion and stenosis of carotid artery
0.000 0.996 0.004
E24 Cushing's syndrome
0.000 0.996 0.004
C80.0 Malignant neoplasm, primary site unknown, so stated
0.000 0.996 0.004
M79.0 Rheumatism, unspecified
0.000 0.996 0.004
I60 Subarachnoid haemorrhage
0.000 0.996 0.004
I61.5 Intracerebral haemorrhage, intraventricular
0.000 0.996 0.004
E80.4 Gilbert's syndrome
0.000 0.996 0.004
I60.4 Subarachnoid haemorrhage from basilar artery
0.000 0.996 0.004
I60.8 Other subarachnoid haemorrhage
0.000 0.996 0.004
Z83.1 Family history of other infectious and parasitic diseases
0.000 0.996 0.004
E28.2 Polycystic ovarian syndrome
0.000 0.996 0.004
C09.9 Tonsil, unspecified
0.004 0.996 0.000
M87.9 Osteonecrosis, unspecified
0.003 0.996 0.000
E24.9 Cushing's syndrome, unspecified
0.000 0.997 0.003
I71.8 Aortic aneurysm of unspecified site, ruptured
0.000 0.997 0.003
I71.5 Thoracoabdominal aortic aneurysm, ruptured
0.000 0.997 0.003
Z83.3 Family history of diabetes mellitus
0.000 0.997 0.003
M87.97 Osteonecrosis, unspecified (Ankle and foot)
0.003 0.997 0.000
Z23.8 Need for immunisation against other single bacterial diseases
0.000 0.997 0.003
Z23.7 Need for immunisation against pertussis alone
0.000 0.997 0.003
Z23.6 Need for immunisation against diphtheria alone
0.000 0.997 0.003
Z23.5 Need for immunisation against tetanus alone
0.000 0.997 0.003
Z23.4 Need for immunisation against tularaemia
0.000 0.997 0.003
Z23.3 Need for immunisation against plague
0.000 0.997 0.003
Z23.2 Need for immunisation against tuberculosis [BCG]
0.000 0.997 0.003
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]
0.000 0.997 0.003
Z23.0 Need for immunisation against cholera alone
0.000 0.997 0.003
Z25.8 Need for immunisation against other specified single viral diseases
0.000 0.997 0.003
Z25.1 Need for immunisation against influenza
0.000 0.997 0.003
Z25.0 Need for immunisation against mumps alone
0.000 0.997 0.003
Z27.9 Need for immunisation against unspecified combinations of infectious diseases
0.000 0.997 0.003
Z27.8 Need for immunisation against other combinations of infectious diseases
0.000 0.997 0.003
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]
0.000 0.997 0.003
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]
0.000 0.997 0.003
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]
0.000 0.997 0.003
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]
0.000 0.997 0.003
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]
0.000 0.997 0.003
Z28.9 Immunisation not carried out for unspecified reason
0.000 0.997 0.003
Z28.8 Immunisation not carried out for other reasons
0.000 0.997 0.003
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons
0.000 0.997 0.003
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure
0.000 0.997 0.003
Z28.0 Immunisation not carried out because of contraindication
0.000 0.997 0.003
I62.1 Nontraumatic extradural haemorrhage
0.000 0.997 0.003
J43.9 Emphysema, unspecified
0.000 0.997 0.003
Z24.6 Need for immunisation against viral hepatitis
0.000 0.997 0.003
Z24.4 Need for immunisation against measles alone
0.000 0.997 0.003
Z24.3 Need for immunisation against yellow fever
0.000 0.997 0.003
Z24.2 Need for immunisation against rabies
0.000 0.997 0.003
Z24.1 Need for immunisation against arthropod-borne viral encephalitis
0.000 0.997 0.003
Z24.0 Need for immunisation against poliomyelitis
0.000 0.997 0.003
Z83 Family history of other specific disorders
0.000 0.997 0.003
I71.9 Aortic aneurysm of unspecified site, without mention of rupture
0.000 0.997 0.003
Z20.1 Contact with and exposure to tuberculosis
0.000 0.997 0.003
I42.2 Other hypertrophic cardiomyopathy
0.000 0.997 0.003
Z24.5 Need for immunisation against rubella alone
0.000 0.997 0.003
E28 Ovarian dysfunction
0.000 0.997 0.003
I42.3 Endomyocardial (eosinophilic) disease
0.000 0.997 0.003
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
0.003 0.997 0.000
Z22 Carrier of infectious disease
0.000 0.997 0.003
T38.1 Thyroid hormones and substitutes
0.000 0.997 0.003
I27.2 Other secondary pulmonary hypertension
0.001 0.997 0.002
I42.5 Other restrictive cardiomyopathy
0.000 0.997 0.003
E24.2 Drug-induced Cushing's syndrome
0.000 0.997 0.003
I71.1 Thoracic aortic aneurysm, ruptured
0.000 0.997 0.003
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.997 0.003
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations
0.000 0.997 0.003
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]
0.000 0.997 0.003
Z20.5 Contact with and exposure to viral hepatitis
0.000 0.997 0.003
Z20.4 Contact with and exposure to rubella
0.000 0.997 0.003
Z20.3 Contact with and exposure to rabies
0.000 0.997 0.003
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission
0.000 0.997 0.003
Z20.0 Contact with and exposure to intestinal infectious diseases
0.000 0.997 0.003
Z26.8 Need for immunisation against other specified single infectious diseases
0.000 0.997 0.003
Z26.0 Need for immunisation against leishmaniasis
0.000 0.997 0.003
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
0.003 0.997 0.000
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium
0.003 0.997 0.000
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
0.000 0.997 0.003
M87.91 Osteonecrosis, unspecified (Shoulder region)
0.003 0.997 0.000
T36.0 Penicillins
0.000 0.997 0.003
M79.01 Rheumatism, unspecified (Shoulder region)
0.000 0.997 0.003
E20-E35 Disorders of other endocrine glands
0.000 0.997 0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.